Blood-collection startup Tasso said it has completed a $6.1 million financing round led by Vertical Venture Partners (VVP), with participation from Techstars and Cedars-Sinai. The funding will help Tasso scale its first product, Tasso OnDemand, which enables self-collection of blood samples, and to add personnel to support commercial growth.
Tasso OnDemand allows people to collect blood at home and mail the samples to the laboratory for analysis. The Seattle-based company said its inaugural product may transform how patients engage with blood testing, optimizing drug efficacy, safety, and adherence, as well as enabling frequent data on vital blood markers for drug development and care management.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!